deltatrials
Completed PHASE4 NCT00092092

Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)

A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma

Sponsor: Organon and Co

Conditions Asthma, Bronchial
Interventions Budesonide inhaler Montelukast chewable tablets Placebo to budesonide inhaler Placebo to montelukast chewable tablets
Updated 7 times since 2017 Last updated: Aug 12, 2024 Started: Oct 31, 2002 Primary completion: Jun 30, 2004 Completion: Jun 30, 2004

A PHASE4 clinical study on Asthma, Bronchial, this trial is completed. The trial is conducted by Organon and Co and has accumulated 7 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Mar 2022 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Mar 2022 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Oct 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Organon and Co
Data source: Organon and Co

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.